Rediff
Home Mail
NewsBusinessMoviesCricketSportsGetahead
Money HomeNewsForexIndicesMutual FundsInsuranceGainersLosers
TrendsStar PortfoliosMy PortfolioMy Watchlist
BusinessEmailGurusTV
News >
Headlines Defence Images Columns Interviews Specials Coverage Videos Archives
Business >
Headlines Columns Specials Personal Finance Interviews Images Technology Auto Union Budget 2026 Archives
Movies >
Headlines Images Interviews Reviews Web Series Videos South Cinema Quiz Hollywood Archives
Cricket >
Headlines Images Stats Women's T20 WC 2026 WT20 2026: Games, Players, Teams IPL 2026 Archives
Sports >
Headlines Formula 1 Football Tennis Chess Hockey
Get Ahead >
Headlines Specials Careers Glamour Health Achievers Finance Travel Food Videos Gadgets Biking Relationships Archives
Money >
News Forex Indices Sectors Mutual Funds Insurance Gainers Losers Trends Star Portfolios My Portfolio My Watchlist
More
Mail Business Email Gurus TV Rediff Podcast
Top StoriesNewsBusinessCricketMoviesSportsGet ahead
  • Headlines
  • Defence
  • Images
  • Columns
  • Interviews
  • Specials
  • Archives

News for 'pharmaceutical drugs'

Cadila launches Remdesivir in India at Rs 2,800 per vial

Cadila launches Remdesivir in India at Rs 2,800 per vial

Rediff.com13 Aug 2020

The company said the drug will be made available across India through the group's strong distribution chain reaching out to government and private hospitals treating COVID-19 patients.

Bharat Biotech cancels Covaxin deals with Brazil firms after graft row

Bharat Biotech cancels Covaxin deals with Brazil firms after graft row

Rediff.com23 Jul 2021

The termination of the MoU came after the deal with the Brazilian government for supply of 20 million doses of the vaccine landed in controversy and attracted investigation by authorities in that country.

Coronavirus impact: Govt restricts exports of 13 APIs, formulations

Coronavirus impact: Govt restricts exports of 13 APIs, formulations

Rediff.com4 Mar 2020

Exports of 13 APIs - including paracetamol, tinidazole, metronidazole, vitamin B1, vitamin B6, vitamin B12, acyclovir, progesterone - along with formulations made from these APIs, would be restricted.

Barsu refinery: People must be taken into confidence, says Uddhav

Barsu refinery: People must be taken into confidence, says Uddhav

Rediff.com28 Apr 2023

Thackeray, whose Maha Vikas Aghadi government fell after a rebellion in June last year by his cabinet colleague Eknath Shinde, who went on to become CM, also warned he would extract revenge for his ouster.

Cipla to price Remdesivir for Covid-19 under Rs 5,000

Cipla to price Remdesivir for Covid-19 under Rs 5,000

Rediff.com25 Jun 2020

Hetero has priced the injectable drug at Rs 5,400 per 100 mg vial. With More drugmakers in line to launch the drug soon, the prices may see a further erosion.

Infosys, L&T are top picks of most brokerages for Samvat 2078

Infosys, L&T are top picks of most brokerages for Samvat 2078

Rediff.com12 Nov 2021

Despite unprecedented levels of uncertainty in Samvat 2077, investors have little to complain about on the returns front. The BSE Sensex delivered returns of 38 per cent in this period, while the Nifty registered a return of over 40 per cent. As is the case in bull markets, companies in the small- and mid-capitalisation basket outperformed the benchmarks, with returns almost twice those of frontliners.

A COVID-19 Vaccine Snapshot

A COVID-19 Vaccine Snapshot

Rediff.com28 Apr 2021

Sputnik V is already approved in India and Sinovac is unlikely to come in as it does not meet the criteria.

Govt may now cap prices of antibiotics

Govt may now cap prices of antibiotics

Rediff.com7 Oct 2019

The intention of the government is to cap prices of drugs that are essential and which the public widely uses.

Court rejects Mamta Kulkarni's plea to de-freeze bank accounts

Court rejects Mamta Kulkarni's plea to de-freeze bank accounts

Rediff.com3 Aug 2021

On April 14, 2016, the crime branch of the Thane police had seized over 20 tonnes of ephedrine and 2.5 tonnes of acetic anhydride drugs from a pharmaceutical factory - Avon Life Sciences - in Solapur and other locations in Thane and Ahmedabad.

50 million doses of Covaxin set to expire in 2023

50 million doses of Covaxin set to expire in 2023

Rediff.com6 Nov 2022

Nearly 50 million doses of Bharat Biotech's COVID-19 vaccine, Covaxin lying with the firm are set to expire early next year as there are no takers owing to poor demand, company sources said.

GSK withdraws sale of Zinetac after health alert

GSK withdraws sale of Zinetac after health alert

Rediff.com26 Sep 2019

GSK is continuing with investigations into the potential source of the NDMA, which is a known environmental contaminant and found in water and foods, including meats, dairy products, and vegetables.

Loss making drugs may go off the shelf

Loss making drugs may go off the shelf

Rediff.com27 Jun 2008

Facing a steep rise in raw material and interest costs, pharmaceutical companies have sought an increase in prices of regulated medicines, saying otherwise they may be forced to curtail production of certain medicines that have become unprofitable.

Smaller towns witness strong growth in sales of medicines

Smaller towns witness strong growth in sales of medicines

Rediff.com27 May 2022

Medicine sales grew at a fast clip in smaller cities like Madurai, Meerut, Agra, and Varanasi in the last 12 months. The domestic pharmaceutical market, overall, has grown 12.3 per cent in this period, according to data from IQVIA MAT for April. MAT refers to the moving annual turnover or the turnover of the last 12 months. The data further showed that the top 30 cities contributed around 32 per cent to sales.

Uncertain future awaits Indian pharma exporters

Uncertain future awaits Indian pharma exporters

Rediff.com25 Aug 2021

As uncertainty looms large in Afghanistan, Indian pharma exporters are apprehensive to send goods to the war-torn country and the target of exporting $126 million worth of pharmaceutical goods to the Taliban-ruling nation now depends on the future outcome. Udaya Bhaskar, director general of Pharmaceuticals Export Promotion Council of India (Pharmexcil) body under the Department of Commerce on Tuesday said as the situation is grim over there and India pharma exporters have cordial relations with Afghanistan. "The projected target for 2021-22 is $126.22 million.

WHO protests common drug names in trademarks

WHO protests common drug names in trademarks

Rediff.com1 Sep 2008

The WHO feels that the practice is not only against international ethics, but also increases the risk of wrong medication. INNs are names that help to identify the chemical composition of a pharmaceutical substance without having to use long and unwieldy chemical names.

Why Chinese imports are likely to continue

Why Chinese imports are likely to continue

Rediff.com26 Jun 2020

Indian auto and pharma industries import several critical components and raw materials from China.

Pharma cos should learn to appreciate FDA norms: Experts

Pharma cos should learn to appreciate FDA norms: Experts

Rediff.com23 Nov 2014

Since 2013, the FDA has banned around 30 Indian drug manufacturing units for various violations

Prices of 70 drugs may be raised

Prices of 70 drugs may be raised

Rediff.com28 Jul 2008

Move is the first in a series of steps to help pharma industry.

India set to run out of critical free drug for HIV/AIDS programme

India set to run out of critical free drug for HIV/AIDS programme

Rediff.com2 Oct 2014

The country had the third-largest number of people living with disease.

India-made Remdesivir may come out in 10 days

India-made Remdesivir may come out in 10 days

Rediff.com19 Jun 2020

The antiviral drug may cost around Rs 55,000 for an 11-dose course, or Rs 5,000 per injection -- much less than the price of imports from Bangladesh, reports Sohini Das.

3 lakh remdesivir to be produced daily in 15 days: Govt

3 lakh remdesivir to be produced daily in 15 days: Govt

Rediff.com18 Apr 2021

The government has also given permission to 20 plants to produce the antiviral drug.

Trade margins capped at 70% for oximeters, BP meters, other medical devices

Trade margins capped at 70% for oximeters, BP meters, other medical devices

Rediff.com14 Jul 2021

The medical devices, which have been in high demand during the Covid-19 pandemic, will now see a drop in prices, as the earlier margins were up to 709 per cent for some of these products.

PE/VC investments in pharma cos cross $1 bn mark

PE/VC investments in pharma cos cross $1 bn mark

Rediff.com6 Oct 2020

Fund managers said investors remained positive on the pharma manufacturing activity in India, which further strengthened during the Covid-19 period, on account of restrictions imposed on pharma imports from China.

200 life-saving drugs to be cheaper

200 life-saving drugs to be cheaper

Rediff.com25 Sep 2007

The medicines whose prices have been reduced belong to therapeutic categories, like dexametozone, betamethazone, ampicillin and ranitidine. The prices of some multi-vitamins and antibiotics would rise a bit.

Exports up 2.14% in July; trade deficit at record $30 bn

Exports up 2.14% in July; trade deficit at record $30 bn

Rediff.com12 Aug 2022

India's exports rose by 2.14 per cent to $36.27 billion in July while the trade deficit almost tripled to $30 billion during the month due to over 70 per cent rise in crude oil imports, according to official data released on Friday. Imports shot up by 43.61 per cent to $66.27 billion in the month compared to July 2021, the data showed. The trade deficit was $10.63 billion in July 2021.

Pfizer withdraws emergency use for its Covid vaccine in India

Pfizer withdraws emergency use for its Covid vaccine in India

Rediff.com5 Feb 2021

An expert panel of the country's drugs regulatory authority had recommended against granting such approval to the firm at this stage just two days ago, officials said.

How India Can Rival China As Production Platform

How India Can Rival China As Production Platform

Rediff.com28 Jul 2023

We have the workforce, now we need to ensure that we take full advantage of game-changing technologies and geopolitical openings, suggests Jayant Sinha, chairman, Parliament's Standing Committee on Finance.

US FDA tightens regulatory noose on Indian drug firms

US FDA tightens regulatory noose on Indian drug firms

Rediff.com17 Sep 2013

Import alert on Ranbaxy's Mohali unit; Strides' injectible arm gets warning letter

MHA issues fresh guidelines on lockdown exemption

MHA issues fresh guidelines on lockdown exemption

Rediff.com25 Mar 2020

The guidelines listed several services including government and private offices that will be out of bounds during the period, while exempting establishments such as hospitals, ration shops, dairies, banks, insurance offices, and print and electronic media. Delivery of all essential goods including food, pharmaceuticals, medical equipment through e-commerce has also been exempted from the purview of the lockdown.

Lower India price tag may help drug MNCs

Lower India price tag may help drug MNCs

Rediff.com8 Nov 2008

A government committee that is looking into the possibility of pre-marketing price negotiation for patented medicines is likely to recommend a lenient view on such medicines, it is learnt. A government committee that is looking into the possibility of pre-marketing price negotiation for patented medicines is likely to recommend a lenient view on such medicines, it is learnt.

Indian pharma exports report double-digit growth after 3 yrs

Indian pharma exports report double-digit growth after 3 yrs

Rediff.com3 May 2019

The only category of pharmaceuticals that showed a negative growth in exports this time was herbal products, exports of which stood at $299 million as compared to $ 312 million in the previous year.

Swiss drug major Roche to axe 4,800 jobs

Swiss drug major Roche to axe 4,800 jobs

Rediff.com17 Nov 2010

The company expects to transfer around 800 jobs internally and about 700 positions to third parties.

Anil Ambani plans foray in drugs retail

Anil Ambani plans foray in drugs retail

Rediff.com22 Nov 2005

Indian drug firms on an African safari

Indian drug firms on an African safari

Rediff.com2 Jan 2006

Excise scare pushes drug firms' investments uphill

Excise scare pushes drug firms' investments uphill

Rediff.com27 Jan 2005

US dream sours for Indian drug firms

US dream sours for Indian drug firms

Rediff.com19 Jul 2005

3 Indian pharma firms named in US Congress price probe

3 Indian pharma firms named in US Congress price probe

Rediff.com9 Oct 2014

Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months

Govt caps trade margin on oxygen concentrators at 70%

Govt caps trade margin on oxygen concentrators at 70%

Rediff.com4 Jun 2021

The government has capped the trade margin on oxygen concentrators at 70 per cent in order to keep in check the price of the much in demand critical life saving component amid the second wave of the coronavirus pandemic. The trade margin has been capped at 70 per cent on price to distributor level on oxygen concentrators. In an official release, the chemicals and fertilisers ministry said the decision has been taken in view of the extraordinary circumstances arising due to the pandemic which has resulted in volatility in Maximum Retail Prices (MRP) of oxygen concentrators.

What exactly is wrong with India's pharma companies?

What exactly is wrong with India's pharma companies?

Rediff.com12 Sep 2017

Sun Pharma and Dr Reddy's top list in terms of those who face most class-action litigation

Modi hints at laws to push doctors to prescribe affordable, generic drugs

Modi hints at laws to push doctors to prescribe affordable, generic drugs

Rediff.com17 Apr 2017

These things are cheaper than equivalent branded drugs, to patients, says Modi

« Prev  |  Next »
Rediff
GET IT ONGoogle Play
GET IT ONApp Store
CONNECT
  • Rediffmail
  • Rediff One
  • - Rediffmail Enterprise
  • - Rediff Ecommerce
  • - Rediff HRMS
  • - Rediff CRM
  • - Rediff ERP
News
  • News
  • Business
  • Movies
  • Sports
  • Cricket
  • Get Ahead
  • Gurus
  • Astrology
  • Rediff Podcast
Stocks
  • BSE Live
  • NSE Live
  • Market News
  • Watchlist
  • Portfolio
Gurus
  • Health
  • Money
  • Career
  • Relationship
About Rediff|Advertise|Privacy Policy|Terms of Service|Investor Relations|Contact Us|© 2026 Rediff.com India Ltd. All rights reserved.